Abstract:Background: The pathological angiogenesis in the retina is a major cause of vision loss at all ages. Vascular endothelial growth factor (VEGF) has been reported as the most potent inducer of retinal neovascularization. We previously demonstrated that integrin-linked kinase (ILK) regulates retinal vascular endothelial proliferation, migration and tube formation. However, little is known about the existence of cross-talk between ILK and VEGF signaling in retinal vascular endothelial cells and the probable regulatory role of ILK during VEGF-induced retinal endothelial cell migration. The purpose of this work was to investigate the role of ILK in VEGF-induced retinal neovascularization. Methods: Cultured retinal endothelial cells (RF/6A) were knocked down for ILK using a small interfering RNA (siRNA). For this, cellular ILK expression was quantified by real-time quantitative PCR, Western blot analysis and immunocytochemical assay, and cytotoxicity of transfection was determined by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. ILK siRNA-transfected RF/6A cells were induced by VEGF, and cell proliferation was determined by the MTT assay, cell migration was measured by cell counting in modified Boyden chambers and cell spreading and tube formation assays were performed. Furthermore, the impact of ILK-specific siRNA on VEGF-induced VEGF receptor 2 (VEGFR-2) phosphorylation and activation of downstream signal pathways were tested by Western blot analysis. Results: Both ILK mRNA and protein levels were virtually undetectable after transfection with ILK siRNA, and blocking the expression of ILK by siRNA significantly inhibited VEGF-induced retinal endothelial cell proliferation, attachment, spreading, migration and tube formation. Knockdown of ILK effectively suppressed VEGF-induced p38 mitogen-activated protein kinase (MAPK) and Akt phosphorylation, but had no effects on VEGFR-2, extracellular signal-regulated protein kinase and Jun N terminus kinase phosphorylation. Conclusion: We conclude that knockdown of ILK with siRNA effectively inhibited VEGF-induced retinal endothelial cell attachment, spreading, migration and tube formation. p38 MAPK and Akt are downstream signaling pathways of the ILK that regulated VEGF-induced retinal neovascularization. Targeting ILK may be a potentially useful therapeutic approach for treating ocular neovascularization.

A Novel Small Peptide H-KI20 Inhibits Retinal Neovascularization Through the JNK/ATF2 Signaling Pathway

A Novel Antiangiogenic Peptide Derived From Hepatocyte Growth Factor Inhibits Neovascularization In Vitro And In Vivo

Inhibition Of Pathologic Corneal Neovascularization By Topical Application Of A Novel Peptide In Vivo

Inhibition of pathologic retinal neovascularization by a small peptide derived from human apolipoprotein(a).

Novel Peptide NT/K-CFY Derived from Kringle Structure of Neurotrypsin Inhibits Neovascularization

Novel Peptide Derived from IGF-2 Displays Anti-Angiogenic Activity in Vitro and Inhibits Retinal Angiogenesis in a Model of Oxygen-Induced Retinopathy.

Inhibition of Pathological Retinal Neovascularization by a Small Peptide Derived from Human Tissue-Type Plasminogen Kringle 2.

A Novel Peptide Specifically Binding to VEGF Receptor Suppresses Angiogenesis in Vitro and in Vivo

Targeting of Integrin-Linked Kinase with Small Interfering RNA Inhibits VEGF-Induced Angiogenesis in Retinal Endothelial Cells

Exosome-mediated Delivery of an Anti-Angiogenic Peptide Inhibits Pathological Retinal Angiogenesis.

Anti-angiogenesis Through Noninvasive to Minimally Invasive Intraocular Delivery of the Peptide CC12 Identified by in Vivo-Directed Evolution.

CM082, a Novel VEGF Receptor Tyrosine Kinase Inhibitor, Can Inhibit Angiogenesis in Vitro and in Vivo.

A Novel Peptide From Human Apolipoprotein(A) Inhibits Angiogenesis And Tumor Growth By Targeting C-Src Phosphorylation In Vegf-Induced Human Umbilical Endothelial Cells

The Inhibitory Effects of Human Recombinant Vascularization Inhibitor K4k5 on Retinal Neovascularization

Down-regulation of Vascular Endothelial Growth Factor and Up-regulation of Pigment Epithelium-derived Factor

Inhibition of Retinal Neovascularization by Gene Transfer of Small Interfering RNA Targeting HIF-1alpha and VEGF.

A Synthetic Peptide Selected by Bioinformatics Inhibits Mouse Corneal Neovascularization

Anti-inflammatory and Antiangiogenic Effects of Nanoparticle-Mediated Delivery of a Natural Angiogenic Inhibitor

A drug-tunable Flt23k gene therapy for controlled intervention in retinal neovascularization

In vitro and in vivo antiangiogenic activity of a novel deca-peptide derived from human tissue-type plasminogen activator kringle 2.

Inhibition Of Pathological Corneal Neovascularization By A Small Peptide Derived From Human Apolipoprotein (A) Kringle V